Unrelated donors are associated with improved relapse‐free survival compared to related donors in patients with myelodysplastic syndrome undergoing reduced intensity allogeneic stem cell transplantation

In conclusion, patients with MDS who received allografts from unrelated donors had a lower risk of relapse and improved relapse‐free survival when compared to patients who received allografts from related donors. These findings should be confirmed in a prospective study. Am. J. Hematol., 2016. © 2016 Wiley Periodicals, Inc.

Source: American Journal of Hematology - July 11, 2016 Category: Hematology Authors: Clinton Yam, Lisa Crisalli, Selina M. Luger, Alison W. Loren, Elizabeth O. Hexner, Noelle V. Frey, James K. Mangan, Amy Gao, Edward A. Stadtmauer, David L. Porter, Ran Reshef Tags: Research Article Source Type: research